Citations to this article
Bichen Zhang, … , Michael H. Nathanson, Xiaoyong Yang
Published November 1, 2019
Citation Information: JCI Insight. 2019;4(21):e127709. https://doi.org/10.1172/jci.insight.127709.
Citation Information: JCI Insight. 2019;4(21):e127709. https://doi.org/10.1172/jci.insight.127709.
Abstract
Worldwide, over a billion people suffer from chronic liver diseases, which often lead to fibrosis and then cirrhosis. Treatments for fibrosis remain experimental, in part because no unifying mechanism has been identified that initiates liver fibrosis. Necroptosis has been implicated in multiple liver diseases. Here, we report that O-linked β-N-acetylglucosamine (O-GlcNAc) modification protects against hepatocyte necroptosis and initiation of liver fibrosis. Decreased O-GlcNAc levels were seen in patients with alcoholic liver cirrhosis and in mice with ethanol-induced liver injury. Liver-specific O-GlcNAc transferase–KO (OGT-LKO) mice exhibited hepatomegaly and ballooning degeneration at an early age and progressed to liver fibrosis and portal inflammation by 10 weeks of age. OGT-deficient hepatocytes underwent excessive necroptosis and exhibited elevated protein expression levels of receptor-interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL), which are key mediators of necroptosis. Furthermore, glycosylation of RIPK3 by OGT is associated with reduced RIPK3 protein stability. Taken together, these findings identify OGT as a key suppressor of hepatocyte necroptosis, and OGT-LKO mice may serve as an effective spontaneous genetic model of liver fibrosis.
Authors
Bichen Zhang, Min-Dian Li, Ruonan Yin, Yuyang Liu, Yunfan Yang, Kisha A. Mitchell-Richards, Jin Hyun Nam, Rui Li, Li Wang, Yasuko Iwakiri, Dongjun Chung, Marie E. Robert, Barbara E. Ehrlich, Anton M. Bennett, Jun Yu, Michael H. Nathanson, Xiaoyong Yang
Citation information
Citations to this article (46)
| Title and authors | Publication | Year |
|---|---|---|
|
OGT mediated HDAC5 O-GlcNAcylation promotes osteogenesis by regulating the homeostasis of epigenetic modifications and proteolysis
Yu Du, Xiang Gao, Xinxin Chen, Hang Liu, Lu Liu, Yue Jiang, Baicheng He, Zhongliang Deng, Chao Liang, Fengjin Guo |
Journal of orthopaedic translation | 2024 |
|
Sugar-coated bullets: Unveiling the enigmatic mystery ‘sweet arsenal’ in osteoarthritis
Liu HZ, Song XQ, Zhang H |
Heliyon | 2024 |
|
O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis.
Vang S, Helton ES, Guo Y, Burpee B, Rose E, Easter M, Bollenbecker S, Hirsch MJ, Matthews EL, Jones LI, Howze PH 4th, Rajasekaran V, Denson R, Cochran P, Attah IK, Olson H, Clair G, Melkani G, Krick S, Barnes JW |
Frontiers in immunology | 2024 |
|
Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases
Mao Z, Mu J, Gao Z, Huang S, Chen L |
Cells | 2024 |
|
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts.
Very N, Boulet C, Gheeraert C, Berthier A, Johanns M, Bou Saleh M, Guille L, Bray F, Strub JM, Bobowski-Gerard M, Zummo FP, Vallez E, Molendi-Coste O, Woitrain E, Cianférani S, Montaigne D, Ntandja-Wandji LC, Dubuquoy L, Dubois-Chevalier J, Staels B, Lefebvre P, Eeckhoute J |
Cell Death and Disease | 2024 |
|
Mitochondria: a new intervention target for tumor invasion and metastasis.
Zhou Q, Cao T, Li F, Zhang M, Li X, Zhao H, Zhou Y |
Molecular medicine (Cambridge, Mass.) | 2024 |
|
Multi-omics after O-GlcNAc alteration identified cellular processes promoting aneuploidy after loss of O-GlcNAc transferase
Boyd SS, Robarts DR, Nguyen K, Villar M, Alghusen IM, Kotulkar M, Denson A, Fedosyuk H, Whelan SA, Lee NC, Hanover J, Dias WB, Tan EP, McGreal SR, Artigues A, Swerdlow RH, Thompson JA, Apte U, Slawson C |
Molecular Metabolism | 2024 |
|
Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models
Hong X, Huang S, Jiang H, Ma Q, Qiu J, Luo Q, Cao C, Xu Y, Chen F, Chen Y, Sun C, Fu H, Liu Y, Li C, Chen F, Qiu P |
Frontiers in Pharmacology | 2024 |
|
Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD
Xie Z, Xie T, Liu J, Zhang Q, Xiao X |
International journal of molecular sciences | 2023 |
|
The Essential Role of O-GlcNAcylation in Hepatic Differentiation
Robarts DR, Kotulkar M, Paine-Cabrera D, Venneman KK, Hanover JA, Zachara NE, Slawson C, Apte U |
2023 | |
|
An update on animal models of liver fibrosis
Wu S, Wang X, Xing W, Li F, Liang M, Li K, He Y, Wang J |
Frontiers in Medicine | 2023 |
|
Deletion of Smooth Muscle O-GlcNAc Transferase Prevents Development of Atherosclerosis in Western Diet-Fed Hyperglycemic ApoE-/- Mice In Vivo
Khanal S, Bhavnani N, Mathias A, Lallo J, Gupta S, Ohanyan V, Ferrell JM, Raman P |
International journal of molecular sciences | 2023 |
|
Emerging field: O-GlcNAcylation in ferroptosis
Zhang H, Zhang J, Dong H, Kong Y, Guan Y |
Frontiers in Molecular Biosciences | 2023 |
|
O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
Seo J, Kim Y, Ji S, Kim HB, Jung H, Yi EC, Lee YH, Shin I, Yang WH, Cho JW |
Frontiers in immunology | 2023 |
|
Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases
Patankar JV, Bubeck M, Acera MG, Becker C |
Frontiers in immunology | 2023 |
|
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
Gonzalez-Rellan MJ, Parracho T, Heras V, Rodriguez A, Fondevila MF, Novoa E, Lima N, Varela-Rey M, Senra A, Chantada-Vazquez MD, Ameneiro C, Bernardo G, Fernandez-Ramos D, Lopitz-Otsoa F, Bilbao J, Guallar D, Fidalgo M, Bravo S, Dieguez C, Martinez-Chantar ML, Millet O, Mato JM, Schwaninger M, Prevot V, Crespo J, Frühbeck G, Iruzubieta P, Nogueiras R |
Molecular Metabolism | 2023 |
|
The essential role of O-GlcNAcylation in hepatic differentiation
Robarts DR, Kotulkar M, Paine-Cabrera D, Venneman KK, Hanover JA, Zachara NE, Slawson C, Apte U |
Hepatology Communications | 2023 |
|
Targeting necroptosis in fibrosis
Hassanein EH, Ibrahim IM, Abd El-Maksoud MS, Abd El-Aziz MK, Abd-alhameed EK, Althagafy HS |
Molecular Biology Reports | 2023 |
|
O-GlcNAc modification of GSDMD attenuates LPS-induced endothelial cells pyroptosis.
Yu F, Zhang Z, Leng Y, Chen AF |
Inflammation research : official journal of the European Histamine Research Society ... [et al.] | 2023 |
|
Efferocytosis in liver disease
Shi H, Moore MP, Wang X, Tabas I |
2023 | |
|
O-GlcNAc transferase acts as a critical nutritional node for the control of liver homeostasis
Ortega-Prieto P, Parlati L, Benhamed F, Regnier M, Cavalcante I, Montabord M, Onifarasoaniaina R, Favier M, Pavlovic N, Magusto J, Cauzac M, Pagesy P, Gautheron J, Desdouets C, Guilmeau S, Issad T, Postic C |
2023 | |
|
Ventromedial hypothalamic OGT drives adipose tissue lipolysis and curbs obesity
Qi Wang, Bichen Zhang, Bernardo Stutz, Zhong-Wu Liu, Tamas Horvath, Xiaoyong Yang |
Science Advances | 2022 |
|
Alkaline nucleoplasm facilitates contractile gene expression in the mammalian heart
A Hulikova, K Park, A Loonat, M Gunadasa-Rohling, M Curtis, Y Chung, A Wilson, C Carr, A Trafford, M Fournier, A Moshnikova, O Andreev, Y Reshetnyak, P Riley, N Smart, T Milne, N Crump, P Swietach |
Basic Research in Cardiology | 2022 |
|
Protein O-GlcNAcylation Regulates Innate Immune Cell Function
H Dong, Z Liu, H Wen |
Frontiers in immunology | 2022 |
|
Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis
Y Zhou, R Wu, X Wang, X Bao, C Lu |
Cell Proliferation | 2022 |
|
O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling
L Wu, Y Cheng, D Geng, Z Fan, B Lin, Q Zhu, J Li, W Qin, W Yi |
Proceedings of the National Academy of Sciences | 2022 |
|
Regulation of Liver Regeneration by Hepatocyte O-GlcNAcylation in Mice
Robarts DR, McGreal SR, Umbaugh DS, Parkes WS, Kotulkar M, Abernathy S, Lee N, Jaeschke H, Gunewardena S, Whelan SA, Hanover JA, Zachara NE, Slawson C, Apte U |
Cellular and Molecular Gastroenterology and Hepatology | 2022 |
|
Assessment of periportal fibrosis in Schistosomiasis mansoni patients by proton nuclear magnetic resonance-based metabonomics models
Rodrigues ML, da Luz TP, Pereira CL, Batista AD, Domingues AL, Silva RO, Lopes EP |
World journal of hepatology | 2022 |
|
Regulation of the urea cycle by CPS1 O-GlcNAcylation in response to dietary restriction and aging
Wu J, Liu J, Lapenta K, Desrouleaux R, Li MD, Yang X |
Journal of Molecular Cell Biology | 2022 |
|
Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
Issad T, Al-Mukh H, Bouaboud A, Pagesy P |
Journal of biomedical science | 2022 |
|
O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis.
Soria LR, Makris G, D'Alessio AM, De Angelis A, Boffa I, Pravata VM, Rüfenacht V, Attanasio S, Nusco E, Arena P, Ferenbach AT, Paris D, Cuomo P, Motta A, Nitzahn M, Lipshutz GS, Martínez-Pizarro A, Richard E, Desviat LR, Häberle J, van Aalten DMF, Brunetti-Pierri N |
Nature Communications | 2022 |
|
Protein O-GlcNAcylation in Metabolic Modulation of Skeletal Muscle: A Bright but Long Way to Go.
Liu Y, Hu Y, Li S |
Metabolites | 2022 |
|
Integration of O-GlcNAc into Stress Response Pathways
Fahie KM, Papanicolaou KN, Zachara NE |
Cells | 2022 |
|
O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
Zhou Y, Li Z, Xu M, Zhang D, Ling J, Yu P, Shen Y |
Cells | 2022 |
|
Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice
Bao X, Ma X, Huang R, Chen J, Xin H, Zhou M, Li L, Tong S, Zhang Q, Shui G, Deng F, Yu L, Li MD, Zhang Z |
Journal of Molecular Cell Biology | 2022 |
|
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
S Mukherjee, M Chakraborty, B Ulmasov, K McCommis, J Zhang, D Carpenter, EN Msengi, J Haubner, C Guo, DP Pike, S Ghoshal, DA Ford, BA Neuschwander-Tetri, A Chakraborty |
Molecular Metabolism | 2021 |
|
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers
DE Spaner |
Frontiers in immunology | 2021 |
|
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
SA Kerk, T Papagiannakopoulos, YM Shah, CA Lyssiotis |
Nature Reviews Cancer | 2021 |
|
Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis
B Zhang, K Lapenta, Q Wang, JH Nam, D Chung, ME Robert, MH Nathanson, X Yang |
The Journal of biological chemistry | 2021 |
|
O -GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis
J Park, HJ Ha, ES Chung, SH Baek, Y Cho, HK Kim, J Han, JH Sul, J Lee, E Kim, J Kim, YR Yang, M Park, SH Kim, TV Arumugam, H Jang, SW Seo, PG Suh, DG Jo |
Science Advances | 2021 |
|
The human O-GlcNAcome database and meta-analysis
E Wulff-Fuentes, RR Berendt, L Massman, L Danner, F Malard, J Vora, R Kahsay, SO Stichelen |
Scientific Data | 2021 |
|
New Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations
Mueller T, Ouyang X, Johnson MS, Qian WJ, Chatham JC, Darley-Usmar V, Zhang J |
2021 | |
|
Necroptosis in Cholangiocarcinoma
S Sarcognato, IE de Jong, L Fabris, M Cadamuro, M Guido |
Cells | 2020 |
|
Methylation-directed glycosylation of chromatin factors represses retrotransposon promoters
M Boulard, S Rucli, JR Edwards, TH Bestor |
Proceedings of the National Academy of Sciences | 2020 |
|
Role of O‐linked N‐acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complications
K Morino, H Maegawa |
Journal of Diabetes Investigation | 2020 |
|
Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3
J Zhang, P Yu, F Hua, Y Hu, F Xiao, Q Liu, D Huang, F Deng, Wei, W Deng, J Ma, W Zhu, J Zhang, S Yu |
Aging | 2020 |
